Sofosbuvir, Velpatasvir

Epclusa 400 MG/100 MG Comprimidos Recubiertos con Pelicula

400 mg + 100 mg comprimido recubierto con películaSpainMarketedAuthorised 14 Apr 2025

In other countries

The same active substances on other registers, the same brand first.

EpclusaBrazil · Gilead Sciences Farmaceutica do Brasil LtdaSame brand
EpclusaCanada · 400 MG + 100 MG · Tablet · Gilead Sciences Canada INCSame brand
EpclusaEuropean Union · Gilead Sciences Ireland UCSame brand
EpclusaCroatiaSame brand
EpclusaItaly · Compressa rivestita con film · Gilead Sciences Ireland UcSame brand
Epclusa 200 mg/50 mg filmomhulde tabletNetherlands · Filmomhulde tablet · Gilead Sciences Ireland UCSame brand
Epclusa 400 mg/100 mg filmomhulde tabletNetherlands · Filmomhulde tablet · Gilead Sciences Ireland UCSame brand

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Sofosbuvir, Velpatasvir

Epclusa 400 MG/100 MG Comprimidos Recubiertos con Pelicula

400 mg + 100 mg comprimido recubierto con películaSpainMarketedAuthorised 14 Apr 2025

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Epclusa 150 mg/37,5 mg, omhuld granulaat in sachetNetherlands · Omhuld granulaat · Gilead Sciences Ireland UC

EPCLUSA 400mg/100mgRomania · 400mg/100mg · compr. film. · Gilead Sciences International Limited

EPCLUSA 400mg/100mgRomania · 400mg/100mg · compr. film. · Gilead Sciences Ireland Uc

Epclusa®Serbia · 400mg+100mg · film tableta · Medicopharmacia DOO Beograd

EPCLUSA 400 mg/100 mg Film-coated TabletSaudi Arabia · Gilead Sciences Ireland Uc

Epclusa Tablet 400MG/100MGSingapore · 400mg + 100mg · tablet, film coated · Gilead Sciences Singapore Pte. LTD.

EpclusaUnited States · 200MG; 50MG, 400MG; 100MG · tablet · Gilead Sciences INC

EpclusaUnited States · 150MG; 37.5MG/PACKET, 200MG; 50MG/PACKET · pellets · Gilead Sciences INC

Packs

Pack	Code	Status
EPCLUSA 400 MG/100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos	767490

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Sofosbuvir, Velpatasvir
Strength: 400 mg + 100 mg
Dosage form: comprimido recubierto con película
Route: vía oral
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 14 Apr 2025
Registration: 1161116001IP
Marketing authorisation holder: Gilead Sciences Ireland Unlimited Company
Procedure: EU centralised
Supply: Diagnóstico Hospitalario

Spain

Epclusa 400 MG/100 MG Comprimidos Recubiertos con PeliculaSofosbuvir + Velpatasvir · 400 mg + 100 mg · comprimido recubierto con películaSpain